Arca biopharma declares special dividend in connection with the proposed merger with oruka therapeutics

Special dividend estimated to be $1.59 per share payment of special dividend conditioned upon arca stockholder approval of the proposed merger with oruka westminster, colo., aug. 16, 2024 (globe newswire) -- arca biopharma, inc. (nasdaq: abio) (“arca”) today announced that its board of directors has declared a special cash dividend (the “special dividend”) in connection with the previously announced merger (the “merger”) with oruka therapeutics, inc. (“oruka”) pursuant to the agreement and plan of merger and reorganization, dated april 3, 2024 (the “merger agreement”).
ABIO Ratings Summary
ABIO Quant Ranking